Ancient Ice Cave Bacteria Reveal Multi-Drug Resistance and Biotech Potential
Researchers have isolated a bacterial strain, Psychrobacter SC65A.3, from a 5,000-year-old ice layer in Romania's Scărișoara Ice Cave, exhibiting resistance to multiple modern antibiotics and possessing over 100 resistance-related genes.
This discovery, reported in Frontiers in Microbiology, suggests natural environments serve as reservoirs for antibiotic resistance genes that predate modern medicine. It also highlights the potential for developing new antimicrobial compounds and biotechnological applications from such ancient microbes.
Discovery from Deep Time
A team of Romanian scientists extracted a 25-meter ice core from the Scărișoara Cave, providing a 13,000-year timeline of environmental conditions. From a 5,000-year-old ice layer, bacterial strains were successfully isolated, including the notable Psychrobacter SC65A.3.
The research, led by scientists such as Dr. Cristina Purcarea from the Institute of Biology Bucharest of the Romanian Academy, involved sequencing the genomes of these bacteria. This process aimed to identify genes crucial for low-temperature survival and, significantly, antimicrobial resistance.
A Millennia-Old Resistance Profile
Despite its millennia-old origin, Psychrobacter SC65A.3 demonstrated resistance to a wide range of modern antibiotics. Laboratory tests evaluated the strain's resistance against 28 antibiotics from 10 classes commonly used in medical treatments.
Resistance was observed against antibiotics such as rifampicin, vancomycin, and ciprofloxacin, drugs vital for treating infections including tuberculosis, colitis, and urinary tract infections (UTIs).
Notably, Psychrobacter SC65A.3 is reported as the first strain of its genus found to be resistant to trimethoprim, clindamycin, and metronidazole, antibiotics prescribed for UTIs and infections of the lungs, skin, blood, or reproductive system.
This extensive resistance profile suggests that bacteria in cold environments may act as natural reservoirs of resistance genes, predating the widespread use of human-developed antibiotics. Furthermore, these bacteria were found to be capable of thriving in harsh conditions, including extreme cold and high salt levels.
Dual Implications: Risks and Opportunities
The presence of such ancient bacterial strains presents a complex scenario, offering both potential risks and exciting opportunities.
Potential Risks
One significant concern involves the potential release of these microbes due to melting ice, a scenario that could facilitate the transfer of resistance genes to modern bacteria. This genetic exchange could potentially exacerbate the global issue of antibiotic resistance by reducing the effectiveness of existing drugs.
Researchers emphasize the importance of careful handling and safety measures in laboratories when working with these ancient bacteria to prevent their uncontrolled spread. While there is no current indication that these cave microbes are harmful to humans, the ability of bacteria to exchange genetic material, including resistance genes, is a known biological mechanism.
Biotechnological Opportunities
Conversely, these ancient bacteria could be a valuable source for biotechnological innovations. Laboratory tests showed that chemicals produced by the ice cave bacteria could kill or inhibit the growth of 14 different types of human disease-causing bacteria, including several designated as high-priority pathogens by the World Health Organization.
The strain Psychrobacter SC65A.3 can inhibit the growth of several antibiotic-resistant "superbugs" and possesses enzymatic activities with biotechnological potential.
Analysis of the Psychrobacter SC65A.3 genome revealed nearly 600 genes with unknown functions, indicating a potential source for novel biological mechanisms. Additionally, 11 genes were identified that may be capable of inhibiting the growth of other bacteria, fungi, and viruses.
These findings suggest that such organisms could inspire the development of new antibiotics and offer applications in industrial biotechnology, where enzymes adapted to function in extreme cold could improve energy efficiency and reduce costs in various industrial processes.
A Deeper Understanding of Nature's Role
The research underscores the natural environment's critical role in the evolution and spread of antibiotic resistance, while also highlighting the unexplored chemical diversity within the natural world. Understanding these ancient microbial systems is becoming increasingly critical in the context of rising global antimicrobial resistance.